Nutex Health Approved for Dual Listing on Nasdaq Texas

Nutex Health Inc. has received approval to dual-list its common stock on Nasdaq Texas. The company announced the approval on September 22, 2026.

The decision for a dual listing, in addition to its existing Nasdaq listing, is intended to potentially enhance liquidity and accessibility for investors. No further details regarding the timeline for the dual listing or its expected impacts were provided.

Nutex Health is a physician-led healthcare services and operations company, with 28 facilities as of the announcement. The company focuses on providing healthcare services and improving operational efficiency.

The company's listing on Nasdaq Texas is part of a broader growth strategy aimed at expanding its operations and enhancing investor relations. Nasdaq Texas is a newer venue designed to attract growth companies.